SEC Form 4 · accession 0001179110-18-002457
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
Feb 20, 2018
Accepted (ET)
Feb 21, 2018 · 8:47 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 20, 2018 | S | 25,000 | $11.68 | D | 196,700 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Weighted average price of shares sold.